510(k) K853279— COXSACKIE A2 CF ANTIGEN, A4, A10 & A16

Substantially Equivalent

Hillcrest Biologicals

Clearance details

Applicant: Hillcrest Biologicals
Product code: Code GNO
Advisory panel: Microbiology
Date received: 1985-08-05
Decision date: 1985-11-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cypress, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.